Free Trial

PMGC (ELAB) Competitors

PMGC logo
$6.18 -0.54 (-8.04%)
Closing price 10/22/2025 04:00 PM Eastern
Extended Trading
$6.28 +0.10 (+1.62%)
As of 09:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ELAB vs. SLXN, MBIO, COCP, ACXP, HOOK, PHXM, IMCC, BFRI, EVAX, and INAB

Should you be buying PMGC stock or one of its competitors? The main competitors of PMGC include Silexion Therapeutics (SLXN), Mustang Bio (MBIO), Cocrystal Pharma (COCP), Acurx Pharmaceuticals (ACXP), HOOKIPA Pharma (HOOK), PHAXIAM Therapeutics (PHXM), IM Cannabis (IMCC), Biofrontera (BFRI), Evaxion A/S (EVAX), and IN8bio (INAB). These companies are all part of the "pharmaceutical products" industry.

PMGC vs. Its Competitors

Silexion Therapeutics (NASDAQ:SLXN) and PMGC (NASDAQ:ELAB) are both small-cap pharmaceutical products companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership.

11.0% of Silexion Therapeutics shares are held by institutional investors. Comparatively, 22.2% of PMGC shares are held by institutional investors. 6.0% of Silexion Therapeutics shares are held by insiders. Comparatively, 0.2% of PMGC shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

PMGC has higher revenue and earnings than Silexion Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Silexion TherapeuticsN/AN/A-$16.44MN/AN/A
PMGC$1.71M1.52-$6.25M-$433.87-0.01

Silexion Therapeutics' return on equity of 0.00% beat PMGC's return on equity.

Company Net Margins Return on Equity Return on Assets
Silexion TherapeuticsN/A N/A -355.74%
PMGC N/A -62.73%-52.83%

Silexion Therapeutics presently has a consensus target price of $75.00, indicating a potential upside of 2,152.25%. Given Silexion Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Silexion Therapeutics is more favorable than PMGC.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Silexion Therapeutics
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
PMGC
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Silexion Therapeutics has a beta of -0.07, meaning that its stock price is 107% less volatile than the S&P 500. Comparatively, PMGC has a beta of 0.32, meaning that its stock price is 68% less volatile than the S&P 500.

In the previous week, PMGC had 3 more articles in the media than Silexion Therapeutics. MarketBeat recorded 4 mentions for PMGC and 1 mentions for Silexion Therapeutics. Silexion Therapeutics' average media sentiment score of 1.00 beat PMGC's score of 0.64 indicating that Silexion Therapeutics is being referred to more favorably in the media.

Company Overall Sentiment
Silexion Therapeutics Positive
PMGC Positive

Summary

Silexion Therapeutics and PMGC tied by winning 6 of the 12 factors compared between the two stocks.

Get PMGC News Delivered to You Automatically

Sign up to receive the latest news and ratings for ELAB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ELAB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ELAB vs. The Competition

MetricPMGCDIVERSIFIED OPS IndustryMulti-Sector SectorNASDAQ Exchange
Market Cap$2.85M$16.72B$15.29B$10.67B
Dividend YieldN/A3.50%3.35%4.86%
P/E Ratio-0.0111.929.9127.13
Price / Sales1.527.706.40126.20
Price / CashN/A41.7739.3661.42
Price / Book0.152.432.146.43
Net Income-$6.25M$953.24M$923.70M$276.63M
7 Day Performance-20.57%-0.88%-0.47%-0.77%
1 Month Performance16.82%-5.60%-4.95%0.68%
1 Year Performance-98.75%8.55%6.40%32.03%

PMGC Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ELAB
PMGC
0.7153 of 5 stars
$6.18
-8.0%
N/A-98.8%$2.85M$1.71M-0.0118Gap Down
SLXN
Silexion Therapeutics
3.2525 of 5 stars
$3.54
-2.7%
$75.00
+2,018.6%
-94.5%$11.38MN/A0.00N/APositive News
MBIO
Mustang Bio
0.5841 of 5 stars
$1.55
-1.3%
N/A-89.6%$11.37MN/A0.00100
COCP
Cocrystal Pharma
2.4163 of 5 stars
$1.06
-2.8%
$6.00
+466.0%
-51.0%$11.20MN/A0.0010Positive News
ACXP
Acurx Pharmaceuticals
2.0146 of 5 stars
$7.01
+0.6%
$31.00
+342.2%
-82.9%$11.05MN/A0.003Gap Down
HOOK
HOOKIPA Pharma
2.2644 of 5 stars
$0.87
flat
$4.50
+417.2%
-78.1%$10.60M$9.35M-0.15160
PHXM
PHAXIAM Therapeutics
N/A$3.10
flat
N/AN/A$10.58MN/A0.0049
IMCC
IM Cannabis
0.0856 of 5 stars
$1.96
-1.5%
N/A-11.8%$10.44M$39.44M0.00340Negative News
Gap Down
BFRI
Biofrontera
1.7473 of 5 stars
$1.00
+0.7%
$2.75
+175.9%
+6.0%$10.04M$37.32M0.0070News Coverage
EVAX
Evaxion A/S
2.224 of 5 stars
$6.53
-7.9%
$13.50
+106.7%
-58.5%$9.94M$3.34M0.0060Upcoming Earnings
Analyst Forecast
INAB
IN8bio
3.6225 of 5 stars
$2.09
-2.8%
$92.00
+4,301.9%
-78.9%$9.76MN/A0.0020Positive News

Related Companies and Tools


This page (NASDAQ:ELAB) was last updated on 10/23/2025 by MarketBeat.com Staff
From Our Partners